Targeting the DNA replication checkpoint by pharmacologic inhibition of Chk1 kinase: a strategy to sensitize APC mutant colon cancer cells to 5-fluorouracil chemotherapy

5-fluorouracil (5-FU) is the first line component used in colorectal cancer (CRC) therapy however even in combination with other chemotherapeutic drugs recurrence is common. Mutations of the adenomatous polyposis coli (APC) gene are considered as the initiating step of transformation in familial and...

Descripción completa

Detalles Bibliográficos
Autores principales: Martino-Echarri, Estefania, Henderson, Beric R., Brocardo, Mariana G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259445/
https://www.ncbi.nlm.nih.gov/pubmed/25301724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259445/
https://www.ncbi.nlm.nih.gov/pubmed/25301724

Ejemplares similares